Publications by authors named "A Minhas"
Cardiogenic shock (CS) is associated with high mortality, particularly in women. With early intervention being a cornerstone of CS management, this study aims to explore whether sex differences exist in the utilization of critical interventions, timing of treatment, and in-hospital mortality for patients with acute myocardial infarction (AMI) and non-AMI-CS. For this retrospective cohort study, we queried the National Inpatient Sample (years 2016-2021) for CS-related hospitalizations.
View Article and Find Full Text PDFReducing low-density lipoprotein cholesterol (LDL-C) levels has been shown to reduce the risk of developing atherosclerotic cardiovascular disease (ASCVD). Statins are the foundation of LDL-C lowering therapy with other non-statin agents used in circumstances where goal LDL-C levels are not reached or owing to intolerance to adverse effects of statins. In 2003, the discovery of the role of the proprotein convertase subtilisin/kexin type 9 (PCSK9) system in promoting elevated LDL-C levels led to new avenues of drug development to achieve target LDL-C.
View Article and Find Full Text PDFArticle Synopsis
- The study examines cardiovascular disease (CVD) mortality trends in Texas and the U.S. from 1999 to 2019, highlighting significant disparities among different demographic and geographic groups.
- A total of over 29 million CVD-related deaths were recorded in the U.S., with Texas accounting for nearly 2 million of those, showing a slight increase in mortality rates after a period of decline.
- Both Texas and national data reveal that certain groups, particularly men, non-Hispanic Black individuals, and those aged 85 and older, experience higher mortality rates; nonmetropolitan areas also show consistently elevated rates compared to metropolitan regions.
Article Synopsis
- A scoping review highlights the lack of guidance for long-term follow-up after elbow arthroplasty, prompting a study on the effectiveness of regular surveillance for identifying failing implants.
- The research analyzed data from 97 elbow arthroplasties performed between 2013 and 2022, revealing that most patients attended follow-up appointments, with special attention on revisions needed after one year.
- Ultimately, the study established surveillance as valuable, successfully identifying all cases of failed implants that required revisions within the designated follow-up period.
Purpose Of Review: To summarize selected late-breaking science on cardiovascular disease (CVD) prevention presented at the 2024 European Society of Cardiology (ESC) Congress.
Recent Findings: Key studies from the 2024 ESC Congress highlight advances in (CVD) management. Apolipoprotein A-1 infusions reduced risk in acute myocardial infarction patients with high LDL cholesterol.